Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5221_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
21 Мб
Скачать
 Infectious Disease and Neurocognition
OTAKE, N., TSURUKIRI, J., NUMATA, J., MORIYA, M., KANEMARU, T., NAGURA, T. & SANO, H.
2023. Herpes simplex virus- induced acute necrotizing encephalopathy in an adult. Acute Med Surg,
10, e818. POOJARI, V. S., SHAH, I. & SHETTY, N. S. 2021. Acute necrotising encephalopathy of childhood sec-
ondary to rotaviral diarrhoea. Indian Pediatr, 58, 491. RADMANESH, F., RODRIGUEZ- PLA, A., PINCUS, M. D. & BURNS, J. D. 2020. Severe cerebral in-
volvement in adult- onset hemophagocytic lymphohistiocytosis. J Clin Neurosci, 76, 236– 237. SARIGECILI, E., UCAR, H. K., HAVALI, C., CANSU, A. & AYDIN, K. 2023. Acute necrotizing en-
cephalopathy associated with RANBP2 mutation: Value of MRI ndings for diagnosis and interven-
tion. Acta Neurol Belg, 123, 571– 582. SHINOHARA, M., SAITOH, M., TAKANASHI, J., YAMANOUCHI, H., KUBOTA, M., GOTO, T.,
KIKUCHI, M., SHIIHARA, T., YAMANAKA, G. & MIZUGUCHI, M. 2011. Carnitine palmitoyl
transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with
various infectious diseases. Brain Dev, 33, 512– 517. SONG, Y., LI, S., XIAO, W., SHEN, J., MA, W., WANG, Q., YANG, H., LIU, G., HONG, Y., LI, P. &
YANG, S. 2021. Inuenza- associated encephalopathy and acute necrotizing encephalopathy in chil-
dren: A retrospective single- center study. Med Sci Monit, 27, e928374. STEVANOVIC, V., BARUSIC, Z., VISKOVIC, K., RODE, O. D. & TESOVIC, G. 2019. Acute necro-
tizing encephalopathy of childhood associated with human herpes virus 6 in Croatia. Neurol Sci, 40,
639– 641. SUN, W., FU, C. & ZHU, X. 2022. Acute necrotizing encephalopathy associated with lymphoma-
associated hemophagocytic lymphohistiocytosis: A case report and literature review. Front Oncol,
12, 986957. TABARKI, B., THABET, F., AL SHAFI, S., AL ADWANI, N., CHEHAB, M. & AL SHAHWAN, S. 2013.
Acute necrotizing encephalopathy associated with enterovirus infection. Brain Dev, 35, 454– 457. TAKANASHI, J. 2009. Two newly proposed infectious encephalitis/ encephalopathy syndromes. Brain
De v, 31, 521– 528. VIRHAMMAR, J., KUMLIEN, E., FALLMAR, D., FRITHIOF, R., JACKMANN, S., SKOLD, M.
K., KADIR, M., FRICK, J., LINDEBERG, J., OLIVERO- REINIUS, H., RYTTLEFORS, M.,
CUNNINGHAM, J. L., WIKSTROM, J., GRABOWSKA, A., BONDESON, K., BERGQUIST, J.,
ZETTERBERG, H. & ROSTAMI, E. 2020. Acute necrotizing encephalopathy with SARS- CoV- 2
RNA conrmed in cerebrospinal uid. Neurology, 95, 445– 449. WANG, Y., YOUNCE, J. R., PERLMUTTER, J. S. & MAR, S. S. 2021. Excellent outcome of acute nec-
rotizing encephalopathy in an adult with bacterial infections, case report. Neurohospitalist, 11,
351– 355. WILLIAMS, T. A., BRUNSDON, R. K., BURTON, K. L. O., DREVENSEK, S., BRADY, C., DALE, R. C.
& MOHAMMAD, S. S. 2019. Neuropsychological outcomes of childhood acute necrotizing enceph-
alopathy. Brain Dev, 41, 894– 900. WONG, A. M., SIMON, E. M., ZIMMERMAN, R. A., WANG, H. S., TOH, C. H. & NG, S. H. 2006.
Acute necrotizing encephalopathy of childhood: Correlation of MR ndings and clinical outcome.
AJNR Am J Neuroradiol, 27, 1919– 1923. WU, L., PENG, H., JIANG, Y., HE, L., JIANG, L. & HU, Y. 2022. Clinical features and imaging manifest-
ations of acute necrotizing encephalopathy in children. Int J Dev Neurosci, 82, 447– 457. YAMAMOTO, H., OKUMURA, A., NATSUME, J., KOJIMA, S. & MIZUGUCHI, M. 2015. A severity
score for acute necrotizing encephalopathy. Brain Dev, 37, 322– 327. YEA, C., BARTON, M., BITNUN, A., MORRIS, S. K., EL TAL, T., ULLOA- GUTIERREZ, R., BRENES-
CHACON, H., YOCK- CORRALES, A., IVANKOVICH- ESCOTO, G., SORIANO- FALLAS, A.,
HERNANDEZ- DE MEZERVILLE, M., GILL, P., NATEGHIAN, A., ASKI, B. H., MANAFI, A. A.,
DWILOW, R., BULLARD, J., PAPENBURG, J., SCUCCIMARRI, R., LEFEBVRE, M. A., COOKE,
S., DEWAN, T., RESTIVO, L., LOPEZ, A., SADARANGANI, M., ROBERTS, A., WONG, J., SAUX,
N. L., BOWES, J., PUREWAL, R., LAUTERMILCH, J., FOO, C., MERCKX, J., ROBINSON, J., YEH,
E. A. & PEDIATRIC INVESTIGATORS COLLABORATIVE NETWORK ON INFECTIONS IN
CANADA (PICNIC). 2023. Neurological involvement in hospitalized children with SARS- CoV- 2
infection: A multinational study. Can J Neurol Sci, 51, 40– 49.
Acute Necrotizing Encephalopathy of Childhood 299
YOSHIDA, T., TAMURA, T., NAGAI, Y., UEDA, H., AWAYA, T., SHIBATA, M., KATO, T. & HEIKE,
T. 2013. MRI gadolinium enhancement precedes neuroradiological ndings in acute necrotizing en­cephalopathy. Brain Dev, 35, 921– 924.
ZHU, H. M., ZHANG, S. M., YAO, C., LUO, M. Q., MA, H. J., LEI, T., YUAN, C. H., WU, G. F., HU, J. S.,
CAI, C. Q. & LIU, Z. S. 2021. e clinical and imaging characteristics associated with neurological sequelae of pediatric patients with acute necrotizing encephalopathy. Front Pediatr, 9, 655074.
19
Dementia Risk Associated
with Infectious Disease
Thomas J. Farrer
Introduction
As with other systems of the body, multiple infectious diseases can negatively af­fect the integrity of the central nervous system (CNS), including bacterial infections, viral infections, parasitic infections, fungal infections, and prion diseases. While a comprehensive discussion of all infectious diseases potentially aecting the CNS is beyond the scope of this chapter, multiple infectious diseases frequently impact CNS function and increase the risk of brain- related disorders, such as delirium, de­mentia, and stroke. is chapter focuses on common CNS infections and how such infections increase the risk of dementia. It also discusses relevant epidemiology and mechanisms of action.
Epidemiology of infection in older adults
Infectious disease among older adults is a signicant public health concern because it accounts for higher rates of hospitalization, more days in the hospital, more health­care utilization, and increased mortality (De Cock et al., 2022; Nelson et al., 2022). Infectious diseases account for one- third of all deaths among individuals who are age 65 years and older (Yoshikawa, 2000), and 50 percent of older adults with infection manifest some degree of delirium (Mouton et al., 2001). More recently, data from the United States Centers for Disease Control and Prevention demonstrate that infection with the severe acute respiratory syndrome coronavirus 2 (SARS- CoV- 2), which causes coronavirus disease 2019 (Covid- 19), was the fourth leading cause of death in 2020 for those age 65 years and older (Centers for Disease Control and Prevention, 2020).
Aging and immunosenescence
Individuals over the age of 65 years are uniquely susceptible to infectious dis­eases. is increased risk is associated with a decline in immune system function

Thomas J. Farrer, Dementia Risk Associated with Infectious Disease In: Medicine

DOI: 10.1093/ oso/ 9780192870414.003.0020
Dementia Risk Associated Infectious Disease 301
(immunosenescence) and an increase in comorbid conditions with age. Older adults have an increased risk of chronic disorders that attenuates host resistance to infec­tion. ere is also an increased risk of nutritional decits among elderly individuals. Malnutrition increases the risk of infection because poor nutrition decreases im­mune function. Additionally, infection increases metabolic demand, putting indi­viduals at risk of nutritional decits, malnutrition, and further infection. e aging process is also associated with anatomical and physiological modications that in­crease the risk of infectious disease. ese include changes in mucociliary clearance in the lungs, decreased urinary clearance from the bladder, decreased gastric acid in the gastrointestinal tract, decreased intestinal motility, and reduced integrity of the blood– brain barrier (Erickson & Banks, 2019; Gavazzi & Krause, 2002). All these age- associated changes make it more dicult for people to ght infection. Certain infectious diseases are also more likely to occur among older adults, including uri­nary tract infections, respiratory tract infections, intra- abdominal infections, infec­tive endocarditis, bacterial meningitis, herpes zoster, and skin infections (Gavazzi & Krause, 2002; Yoshikawa, 2000). Less clear from the research literature is whether there is the possibility that infection in earlier adult years sets the stage for a subse­quent cascade of inammatory processes that impact cognitive function only later in life. In fact, infection in childhood may be protective in nature, with one study sug­gesting that earlier illnesses somehow buer an individual from late- life dementia (Rotstein & Levine, 2021). Nevertheless, as enumerated in the following section, there is evidence of dementia risk following infection.
Infectious disease and dementia risk
A 2019 meta- analysis (Warren- Gash et al., 2019) examined the risk of mild cognitive impairment and dementia among individuals with human herpesvirus infection, herpes simplex virus (HSV), varicella zoster virus, Epstein– Barr virus, and cytomeg­alovirus. Overall, this meta- analysis suggested that past infection alone was not as­sociated with an increased risk of dementia or mild cognitive impairment. However, viral reinfection or recent infection seems to lead to systemic inammation, glial ac­tivation, and neuroinammation that may serve as mechanisms of action for cogni­tive decline and dementia in older adults. is meta- analysis acknowledges that the included studies have variable methodological quality and heterogeneity. However, the authors suggest the most robust nding was from an ophthalmic variant of var­icella zoster virus, which results in vasculopathy and replication in cerebral arteries, increasing the risk of vascular injury and subsequent cognitive symptoms (Warren­Gash et al., 2019).
Ou et al. (2020) demonstrated in a recent meta- analysis that several infec­tious agents are associated with an increased risk of Alzheimer’s disease, in­cluding Chlamydia pneumoniae (odds ratio: 4.39), human herpesvirus 6 (odds
 Infectious Disease and Neurocognition
ratio: 3.97) Epstein– Barr virus (odds ratio: 1.45), HSV- 1 (odds ratio: 1.34), and the Herpesviridae viruses (odds ratio: 1.41).
A recent study of 1000 individuals with herpes was conducted with baseline cog­nitive testing and brain imaging. e average follow- up time was 3.4 years (Duggan et al., 2022). Imaging markers included gray matter and white matter volume. e study showed no signicant dierences in baseline brain volumes between those with herpes and without. However, over the study period, the virus was associ­ated with accelerated longitudinal declines in white matter volume, with the most prominent atrophy in temporal lobe regions. e study also examined ve cognitive domains among 2160 individuals across 8.6 years. is longitudinal analysis of cog­nitive function demonstrated that those individuals with herpes displayed greater declines in areas of attention but no other aspect of cognition (Duggan et al., 2022).
In summary, multiple studies appear to demonstrate a relationship between infec­tious disease and neurodegenerative disorders, although a 2022 umbrella review (X. Wang et al., 2022) questioned the study quality of previously published systematic reviews and meta- analyses. ere are other lines of evidence supporting the role of infection in dementia, including large population- based designs.
Evidence from large population- based designs
Increased risk of dementia has been associated with viral infections in multiple studies, including postmortem studies, epidemiologic studies (Lovheim et al., 2015a, 2015b), and genome- wide association studies (Burt et al., 2008; Kuo et al.,
2020). Robust evidence of a connection between dementia and infectious diseases is provided by large cross- sectional cohorts. Dunn et al. (2005) studied 9000 older adults with dementia and 9000 without, examining infection odds ratios in dierent age groups over the preceding 4 years. When collapsed across all age groups of older adults aged 60 years and older, the odds ratio of having an infection in the previous 4 years before dementia diagnosis was 1.3. ose aged 84 years and older had the highest chance of infection (odds ratio: 1.4) in the 4 years before dementia diagnosis. While these are small odds ratios, a large sample size suggests that there is an in­creased risk of dementia associated with infectious disease. However, the study did not dierentiate the etiology of infection. ese authors postulated that the mech­anism of action is associated with the inammatory response to infection and that this mechanism may promote the onset of dementia (Dunn et al., 2005).
Similarly, a recent large population- based cohort study examined the associa­tion between hospitalizations with infections and the incidence of dementia diag­nosis. e baseline cohort of individuals without dementia was 15,688 individuals. Hospitalization due to infection occurred in 5999 participants. is study showed that dementia rates were higher among individuals with exposure to an infection rel­ative to individuals without exposure. Patients hospitalized with infection were two times more likely to experience incident dementia. A post hoc analysis from these
Dementia Risk Associated Infectious Disease 303
data that excluded individuals who developed dementia less than 3 years or more than 20 years from baseline showed an adjusted hazard ratio of 5.77. In addition, the rates of dementia were higher among individuals hospitalized for urinary tract infections, respiratory infections, hospital- acquired infections, skin infections, and blood and circulatory system infections (Bohn et al., 2023), all of which are common infections in older adults.
A large population- based study (Chen et al., 2017) examined the link between herpes zoster and dementia diagnosis at a follow- up of 6.2 years. Comparing 39,000 individuals with herpes zoster to a control group of 39,000 individuals without the virus, the researchers found an average 12- percent increased risk of dementia among those with the virus. e study also examined interactions with other health factors and the impact of antiviral treatment. is study demonstrated that with antiviral treatment, the risk of developing dementia resulted in a hazard ratio of 0.47, sug­gesting a reduced risk of dementia in the context of antiviral agents. Interactions of comorbid factors that increase the risk of dementia included the presence of herpes zoster and depression (hazard ratio: 1.29) and herpes zoster with alcohol- use dis­order (hazard ratio: 5.57) (Chen et al., 2017). In another study, researchers exam­ined the risk of Alzheimer’s disease with a large population cohort of over 4 million individuals over 10 years. e study demonstrated that in over 40,000 cases of Alzheimer’s disease matched against 1.6 million controls, the burden of infectious disease was associated with an increased risk of Alzheimer’s disease, with an odds ratio of 1.05 (95 percent condence interval: 1.02– 1.08) (Douros et al., 2021).
A large population- based study of dementia risk showed that HSV infections had a hazard ratio of 2.56, indicating a higher risk of dementia. e study showed that among those with HSV infection who then subsequently received anti- herpetic medication, there was a reduced risk of dementia, with a hazard ratio of 0.092 (Tzeng et al., 2018).
Levine et al. (2023) conducted a major archival study using two databases to investigate the connection between neurodegenerative and infectious diseases. Specically, using medical billing codes, the study initially examined the associ­ation between six neurodegenerative diseases (NDDs) and infection in a longitu­dinal cohort of over 300,000 individuals. is initial analysis identied 45 separate NDD × infection associations. e authors then veried 22 of these associations in a separate large cross- sectional database of over 500,000 individuals in the United Kingdom. is study also included a control cohort of healthy individuals matched for age and ethnicity, which included over 96,000 individuals with no NDD. e six NDDs examined in the study included Alzheimer’s disease, amyotrophic lat­eral sclerosis, multiple sclerosis, Parkinson’s disease, vascular dementia, and ge­neral dementia with no specic etiology. Aer replicating the 22 NDD × infection associations, the authors provide detailed odds ratios or hazard ratios of each NDD across multiple infection types and stratify these by the time of infection, ranging from 1 to 15 years before NDD diagnosis. e largest hazard ratio was
30.72 (95 percent condence interval: 11.8– 79.6), which strongly demonstrated
 Infectious Disease and Neurocognition
an association between viral encephalitis and Alzheimer’s disease. Additionally, individuals with inuenza and pneumonia were more likely to develop ve of the six studied NDDs. Another important nding from the study is that the in­creased risk of NDD persists years aer the initial virus infection. For example, the authors demonstrated that even 15 years before Alzheimer’s diagnosis, inu­enza with pneumonia resulted in a hazard ratio of 1.91. Infection within the last 5 years resulted in a hazard ratio of 6.76, and infection within the last year resulted in a hazard ratio of 23. Similar risks were identied in other NDDs, suggesting that more recent infections increase the risk of dementia. For example, inuenza within the last 5 years resulted in a hazard ratio of 8.2, suggesting an increased risk of general all- cause dementia, but this hazard ratio increased to 25 if inuenza occurred in the last year (Levine et al., 2023). In summary, these large population­based studies demonstrate a robust association between infectious disease and dementia. ere are, of course, some contradictory research ndings, and not all infectious diseases are associated with dementia. For example, dementia seems to be rarely associated with the parasitic infection known as neurocysticercosis, with one cross- sectional study of 592 individuals suggesting the prevalence of de­mentia around 1.3 percent (Varma & Gaur, 2002). e prevalence may be higher in a hospitalized sample, with one study from India suggesting that 8 percent of hospitalized dementia cases were associated with neurocysticercosis (Jha & Patel,
2004). Additionally, while the literature on Lyme disease is mixed, some ndings suggest an association between Lyme disease and decreased cognitive function, but there is little to no evidence that Lyme disease increases the risk of dementia (Almeida & Lautenschlager, 2005). Additionally, in a cross- sectional study of a community- dwelling population, Helicobacter pylori was not associated with ge­neral dementia (Fani et al., 2018). However, it may increase the risk of Parkinson’s disease (X. Wang et al., 2022), and there may be interaction eects with various periodontal pathogens by which the presence of both H. pylori and periodontal pathogens uniquely increases the risk of dementia (Beydoun et al., 2021). Lastly, there are viral infections that do not have enough research literature to this point. For example, a case study of chronic dengue virus suggested the virus may per­sist in the CNS and can contribute to progressive dementia (Johnson et al., 2019). However, it would be prudent to avoid generalization from a single case study.
Mechanisms of action and the viral infection theory
Two main pathways exist for dementia following infection disease: direct or indi­rect. A direct mechanism suggests that infection enters the brain directly and causes inammation and cell death. Primary CNS infections are an example of a direct mechanism. Conversely, an indirect mechanism is associated with systemic infec­tion and inammation elsewhere in the body. Peripheral or systemic infection in­creases inammation systemwide, and prior studies suggest that a general increase
Dementia Risk Associated Infectious Disease 305
in inammation acts on vascular health and increases the risk of cognitive decline (De Vlieger et al., 2022).
Direct pathway
e proposed mechanistic pathway for the viral infection theory suggests that the virus enters the CNS via the blood– brain barrier or the blood– cerebrospinal uid barrier through transcellular or pericellular migration. Once the virus is within the CNS, it replicates resulting in an immune response, with the release of cytokines, chemokines, antimicrobial peptides, and reactive oxygen species. ere is sec­ondary activation of microglia and astrocytes and subsequent cell death. While the host may be able to recover from infection, the viral infection theory proposes that the latent virus may result in reinfection multiple times across the lifespan and ulti­mately increase the risk of dementia over time (De Vlieger et al., 2022). Additionally, neurodegeneration is induced in infection when a virus disrupts homeostatic pro­cesses at the cellular level. is includes an increased expression of quinolinic acid in the brain, which is excitotoxic. is results in increased calcium in the cytosol, depletion of adenosine triphosphate, and increased free radicals. Cell death is the ul­timate consequence of this cascade, and biomarkers of this process have been found in individuals with Alzheimer’s disease and mild cognitive impairment (De Vlieger et al., 2022).
Indirect pathway
e proposed mechanism for the indirect pathway suggests that infections in the peripheral system result in similar proinammatory markers. ese biomarkers can then be transported to the CNS, particularly when the blood– brain barrier or blood– cerebrospinal uid barrier is compromised. ese biomarkers then transfer a proinammatory signal to tissue in the CNS. As such, a similar cascade of events occurs in CNS tissue even if the virus was not initially present there (De Vlieger et al., 2022).
Other mechanisms
While the direct and indirect mechanisms for NDD aer infection have been studied extensively, an additional hypothesis has examined the role of extracellular vesicles. roughout the body, and particularly in the CNS, extracellular vesicles play a role in transporting multiple important molecules needed for metabolism, protein syn­thesis, and cellular maintenance, including proteins, lipids, and nucleic acids. Recent studies have suggested that infectious diseases can interfere with extracellular vesicle
 Infectious Disease and Neurocognition
pathways. Further, cellular vesicles can transport viral deoxyribonucleic acid. As vir­uses interfere with extracellular vesicle transport, the metabolic and homeostatic function of cells is reduced, and cellular function fails. e disruption of extracel­lular vesicles increases the occurrence of misfolded proteins, both within neurons and in the extracellular space, and has been associated with the prototypical plaques and tangles observed in Alzheimer’s disease (De Vlieger et al., 2022).
Primary central nervous infection: Classification and specific infections
Infections aecting CNS function fall into multiple categories that are briey re­viewed here.
Meningitis
Meningitis is infection and inammation of the meninges covering the brain and spinal cord, which can result from bacterial, viral, or fungal infection. Meningitis, regardless of etiology, is associated with several neurological and cognitive sequelae. Infections from bacteria can lead to meningitis and brain abscesses. When a bac­terial infection is the primary cause, the infection typically originates elsewhere in the body. ese infections can have characteristic symptoms, including fever, neck stiness and neck pain, headache, and sensitivity to sound and light (Blumenfeld,
2010). Viral infection can also iname the meninges and cause similar symptoms. Viral meningitis is also termed aseptic meningitis. Treatment is challenging in viral meningitis, which can be associated with several viruses, including herpes­viruses, human immunodeciency virus (HIV), and enteroviruses. Viruses may also enter the brain parenchyma and result in viral encephalitis. e most common form of viral encephalitis is HSV. Viral encephalitis from herpes is a medical emer­gency because it can cause coma or death. is form of encephalitis has a predilec­tion for limbic regions involving frontal and temporal lobes (Blumenfeld, 2010). Severe meningitis can cause ischemic brain injury and infarction, vasculitis, ce­rebral abscesses, parenchymal bleeding, and increased risk of seizure, delirium, and dementia (Farmen et al., 2021). Most meningitis cases are caused by one of three agents: Haemophilus inuenza type b, Neisseria meningitides, or Streptococcus pneumonia.
Encephalitis
An infection of the encephalon (i.e., brain tissue or parenchyma) results in enceph­alitis. Encephalitis can be caused by multiple bacteria, viral, parasitic, or fungal
Dementia Risk Associated Infectious Disease 307
pathogens, and a comprehensive discussion of all such pathogens is not included here. In general, however, encephalitis is typically described as primary or sec­ondary. Primary encephalitis refers to an infection directly to the brain. Secondary encephalitis is a post- infection encephalitis in an immune response to a dormant virus or immunization (i.e., attenuated virus). While several viruses have been im­plicated in encephalitis, the most common viral infections resulting in encephalitis include herpes simplex, Epstein– Barr, varicella zoster, enteroviruses, and arbo­viruses. As with meningitis, encephalitis results in multiple psychiatric and neu­rological sequelae. Inammation results in edema, leading to tissue damage and ischemic injury. ere is also an increased risk of stroke and seizure, and multiple studies demonstrate an increased risk of dementia, even aer infection recovery (Campos et al., 2021; Hokkanen & Launes, 1997). Individuals with measles can have post- infectious encephalitis. is occurs when there is a delay in encephalitis, sometimes days or weeks aer the initial infection, making it dicult to associate the encephalitis with illness. Transverse myelitis occurs when infection results in inammation of the spinal cord. is is frequently related to enteroviruses but can occur in multiple viral infections. Common symptoms of transverse myelitis in­clude pain, sensory changes, weakness, and bladder or bowel control diculties when lower aspects of the spine are involved. HIV- associated cognitive change is frequently identied in the literature, and numerous studies have demonstrated that HIV can result in dementia and increase the risk of other conditions, such as Alzheimer’s disease. e John Cunningham virus (commonly called the JC virus) can result in demyelination throughout the CNS, resulting in progressive multi­focal leukoencephalopathy. e JC virus is endemic in most populations, with 70– 90 percent of the population having this virus in a harmless dormant form. However, the risk of progressive multifocal leukoencephalopathy from the JC virus increases among individuals who are immunocompromised. For instance, this con­dition has been identied among individuals with AIDS and multiple sclerosis or other immunocompromised states. Common symptoms include dementia, blind­ness, paralysis, and seizures. Progressive multifocal leukoencephalopathy is typi­cally fatal (Blumenfeld, 2010).
Delirium
Although delirium is clinically distinct from dementia, it does warrant discussion here given that infections oen result in delirium, which is oen misdiagnosed as dementia. Delirium is a confusional state, with an acute onset that typically presents with uctuation in mental status. ere are typically changes in arousal and disturb­ances in attention, and patients are oen illogical and have uctuations in alertness. Patients may even have delusions, hallucinations, or psychomotor features. Delirium is quite common, with almost 60 percent of patients in post- acute care or assisted­living facilities experiencing delirium at some point. Among older adults, the most